top of page

PISTON BIO
Developing Extended Half-Life Medicines for Cancer

Extending exposure. Expanding therapeutic potential.

Piston Bio is developing extended half-life medicines designed to provide sustained therapeutic exposure and unlock new opportunities in cancer treatment.

PISTON BIO

Developing Extended Half-Life Medicines for Cancer

ChatGPT Image Sep 24, 2026, 07_47_23 PM.png

Pipeline

PST-101
Extended Half-Life A2A Antagonist
Oncology

PST-102
Extended Half-Life TLR7/8 Agonist
Oncology

ChatGPT Image Sep 24, 2026, 08_09_07 PM.png
ChatGPT Image Sep 24, 2026, 08_17_26 PM.png
ChatGPT Image Sep 24, 2026, 08_22_02 PM.png
ChatGPT Image Sep 24, 2026, 08_28_05 PM.png
hong.jpg
ribas.png
daud.png
zibelman.png

Building the next generation of extended half-life medicines for cancer.

Company Presentation
Contact Us
bottom of page